Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study | Zendy

AI Assistant Blog Pricing

Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.